1st human application of CRISPR could end sickle cell disease – Daily Californian
|
1st human application of CRISPR could end sickle cell disease
Daily Californian The breakthrough gene-editing technology CRISPR-Cas9, which was co-discovered by Jennifer Doudna, a UC Berkeley professor of biochemistry and molecular biology, may soon be applied to humans for the first time to treat sickle cell disease. CRISPR works … |
